-
Mashup Score: 5
The approval was based on improved overall and PFS with irinotecan liposome alongside oxaliplatin, fluorouracil, and leucovorin vs gemcitabine plus nab-paclitaxel.
Source: www.medscape.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9
The approval was based on improved overall and PFS with irinotecan liposome alongside oxaliplatin, fluorouracil, and leucovorin vs gemcitabine plus nab-paclitaxel.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
Newly approved updated labeling allows patients to receive full-body MRI scans while implanted with the Abbott dorsal root ganglion (DRG) neurostimulation system.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5CRISPR-Based Gene Therapy Earns Beta Thalassemia Approval - 4 month(s) ago
Exa-cel earned its second FDA approval. The one-time therapy, which has a list price of $2.2 million in the United States, should be available for patients early this year.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3
HyQvia, which combines immunoglobulin with hyaluronidase, is administered subcutaneously by a healthcare professional or the patient or caregiver, after appropriate training.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11FDA approves topical treatment for junctional, dystrophic EB - 4 month(s) ago
This is the first approved treatment for wounds associated with JEB and the second for patients with DEB, following the approval of a topical gene therapy in May 2023.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 15FDA Updates Labels for Two Cholesterol-Lowering Agents - 5 month(s) ago
New bempedoic acid and bempedoic acid/ezetimibe labels add primary hyperlipidemia and remove the maximally tolerated statin requirement and statement on the effect on mortality.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 19FDA OKs Iptacopan to Treat Paroxysmal Nocturnal Hemoglobinuria - 5 month(s) ago
This marks the first oral monotherapy approved for the rare blood disorder.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2FDA Approves Pirtobrutinib for Previously Treated CLL/SLL - 5 month(s) ago
The approval is the second this year for the reversible, highly selective kinase inhibitor following a January approval in mantle cell lymphoma.
Source: www.medscape.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia - 5 month(s) ago
The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.
Source: www.medscape.comCategories: General Medicine News, Onc News and JournalsTweet
❗ #FDAapproves irinotecan liposome in combination with oxaliplatin, fluorouracil, and leucovorin for the first-line treatment of metastatic pancreatic adenocarcinoma. https://t.co/aNGYwkRWU5 https://t.co/k5M3LskglT